Allurion secures new patent for gastric balloon technology
NATICK, Mass. - Allurion Technologies, Inc. (NYSE: ALUR), a company focused on obesity treatment solutions, has expanded its ...
Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs
Key Takeaways Allurion Technologies said it planned to test its gastric balloon with the key ingredient in popular ...
Allurion gets ‘Notification of Issuance’ from USPTO for obesity treatment
Allurion Technologies (ALUR) announced that it has received an Issue Notification from the U.S. Patent and Trademark Office USPTO dated January ...
Eagle-Tribune10d
Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity
This patent covers additional claims for an enhanced, next-generation version of Allurion’s proprietary Balloon technology and the introduction of innovative features, particularly to the ...
Joplin Globe10d
Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity
Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has received an Issue Notification from the U.S. Patent and ...